3K3A-APC for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT05039268
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG:
3K3A-APC Protein
Sponsor
Macquarie University, Australia
Collaborators
[object Object]